Cargando…

A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma

BACKGROUND: 13‐Deoxy, 5‐iminodoxorubicin (GPX‐150) is a doxorubicin (DOX) analog synthesized to reduce the formation of reactive oxygen species and the cardiotoxic metabolite, doxorubiciniol, the two pathways that are linked to the irreversible, cumulative dose‐dependent cardiotoxicity of DOX. In a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Tine, Brian A., Agulnik, Mark, Olson, Richard D., Walsh, Gerald M., Klausner, Arthur, Frank, Nicole E., Talley, Todd T., Milhem, Mohammed M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558450/ https://www.ncbi.nlm.nih.gov/pubmed/31016866 http://dx.doi.org/10.1002/cam4.2136

Ejemplares similares

Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma
por: Imai, Reiko, et al.
Publicado: (2018)

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma
por: Villalobos, Victor M., et al.
Publicado: (2019)

Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
por: Yi, Renxin, et al.
Publicado: (2020)

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas
por: Monga, Varun, et al.
Publicado: (2020)

Epidemiological study of soft‐tissue sarcomas in Ireland
por: Bhatt, Nikita, et al.
Publicado: (2015)

Targeted therapies for the treatment of soft tissue sarcoma
por: Fuchs, Jeffrey W., et al.
Publicado: (2023)

Clinical outcomes of radio‐hyperthermo‐chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched‐pair cohort study
por: Aiba, Hisaki, et al.
Publicado: (2018)

Efficacy and safety of anlotinib in patients with unresectable or metastatic bone sarcoma: A retrospective multiple institution study
por: Liu, Zhiyong, et al.
Publicado: (2021)

Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience
por: Orbach, Daniel, et al.
Publicado: (2018)

Irreversible Electroporation Ablation (IRE) of Unresectable Soft Tissue Tumors: Learning Curve Evaluation in the First 150 Patients Treated
por: Philips, Prejesh, et al.
Publicado: (2013)

GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome
por: Zhou, Jing‐Dong, et al.
Publicado: (2016)

Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database reporta
por: Corey, Robert M, et al.
Publicado: (2014)

Turning ‘Cold’ tumors ‘Hot’: immunotherapies in sarcoma
por: Rytlewski, Jeff, et al.
Publicado: (2021)

Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists
por: Baheti, Akshay D., et al.
Publicado: (2017)

Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas
por: Long, Zuoyao, et al.
Publicado: (2023)

Clinical outcomes of non‐osteogenic, non‐Ewing soft‐tissue sarcoma of bone––experience of the Toronto Sarcoma Program
por: Veitch, Zachary W., et al.
Publicado: (2020)

Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review
por: Chen, Huan-Huan, et al.
Publicado: (2022)

Very long‐term survivors among patients with metastatic soft tissue sarcoma
por: Carbonnaux, Mélodie, et al.
Publicado: (2019)

Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma
por: Jain, Varsha, et al.
Publicado: (2019)

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
por: Sutera, Philip, et al.
Publicado: (2018)

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
por: Heater, Natalie K., et al.
Publicado: (2023)

Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas
por: Penumarthy, Neela L., et al.
Publicado: (2019)

Treatment options in unresectable soft tissue and bone sarcoma of the extremities and pelvis – a systematic literature review
por: Smolle, Maria Anna, et al.
Publicado: (2020)

Editorial: New therapeutics for soft tissue sarcomas
por: Weetall, Marla, et al.
Publicado: (2023)

Immune checkpoint inhibitor resistance in soft tissue sarcoma
por: Eulo, Vanessa, et al.
Publicado: (2022)

Advances in soft-tissue sarcoma – There are no mistakes, only lessons to learn!
por: Rastogi, Sameer, et al.
Publicado: (2019)

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group (EORTC‐STBSG)
por: Lindner, Lars H., et al.
Publicado: (2018)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors
por: Joseph, Cissimol P., et al.
Publicado: (2021)

Marital status and survival in patients with soft tissue sarcoma: A population‐based, propensity‐matched study
por: Zhang, Shi‐long, et al.
Publicado: (2019)

Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue
por: Langsner, R. J., et al.
Publicado: (2011)

Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma
por: Wang, Zhi‐Ming, et al.
Publicado: (2020)

Metastases of soft tissue sarcoma to the liver: A Historical Cohort Study from a Hospital‐based Cancer Registry
por: Okamoto, Masanori, et al.
Publicado: (2020)

Translational Regulation of GPx-1 and GPx-4 by the mTOR Pathway
por: Reinke, Emily N., et al.
Publicado: (2014)

Extent of tumor fibrosis/hyalinization and infarction following neoadjuvant radiation therapy is associated with improved survival in patients with soft‐tissue sarcoma
por: Rao, Sneha R., et al.
Publicado: (2021)

New Developments in Mammalian Target of Rapamycin Inhibitors for the Treatment of Sarcoma
por: Agulnik, Mark
Publicado: (2012)

Osteogenic Sarcoma of the Maxilla: Neutron Therapy for Unresectable Disease
por: Smoron, Geoffrey L., et al.
Publicado: (1999)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer
por: Peixoto, Renata D’Alpino, et al.
Publicado: (2015)

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
por: Lou, Emil, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nknr490hpba742906io3qvl1j8